This information was published on 2026-06-18T02:26:08 for IP Right Filed Published.
| Field | Value |
| (210) | 2663932 (IR 1919039) |
| (220) |
13 May 2026
|
| (300) |
BX, 09 Jan 2026, 1540388
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 5
Chemical preparations for vaccines; biochemical preparations for vaccines; vaccine adjuvants; adjuvants for medical purposes. |
| (540) | AS04 |
| (550) | Word |
| (730) |
GlaxoSmithKline Biologicals S.A.
|
Find out more about publications on the About page.